UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Amgen, Chong Kun Dang to sell osteoporosis drug in Korea
Amgen Korea said it signed a joint promotion agreement with Korean pharmace...
by Marian Chu
|
2017-09-13 18:33
라인
Alvogen Korea to sell Vivus’ obesity drug
Alvogen Korea said Wednesday that it gained exclusive marketing rights to s...
by Marian Chu
|
2017-09-13 18:16
라인
ASEAN officials visit JW’s manufacturing plant
Officials involved in good manufacturing practice (GMP) in 10 member nation...
by Song Soo-youn
|
2017-09-13 18:07
라인
Ewha Hospital well on its way toward more spacious wards
Ewha Womans University Seoul Hospital, which seeks to expand the size of ho...
by Yang Geum-deok
|
2017-09-13 18:03
라인
MFDS chief embroiled in ‘abuse of power’ controversy
It seems as if not a day passes by without Food and Drug Safety Minister Ry...
by Song Soo-youn
|
2017-09-13 17:02
라인
Opdivo’s expanded indications ease cancer patients’ worries
Ono Pharma Korea and Bristol-Myers Squibb said Wednesday that their blockbu...
by Marian Chu
|
2017-09-13 16:57
라인
AMC professor introduces new method of intracranial aneurysms
Professor Seo Dae-chul of Asan Medical Center (AMC) has introduced a new me...
by Constance Williams
|
2017-09-13 16:15
라인
Severance Hospital revamps emergency care center
The nation’s large-sized hospitals chronically suffer overcrowding at their...
by Lee Hye-seon
|
2017-09-13 16:08
라인
Anticoagulant drugs will add SJS Warning
The approval conditions of nine medicines that include rivaroxaban, such as...
by Lee Hye-seon
|
2017-09-13 15:55
라인
Hanall Biopharma made $81-million technology export to China
Hanall Biopharma said Tuesday it has licensed out two new bio drugs under d...
by Lee Hye-seon
|
2017-09-13 13:23
라인
New VC investments in bio, medical fields fall sharpest in H1
New venture capital investments in bio and medical industries have fallen m...
by Nam Doo-hyun
|
2017-09-13 13:23
라인
China, Australia emerge as promising markets for medical equipment makers
Australia has emerged as the promising market for Korean medical equipment ...
by Nam Doo-hyun
|
2017-09-12 17:40
라인
365mc unveils AI liposuction system
365mc Networks, Korea’s largest group of obesity treatment clinics, has unv...
by Song Soo-youn
|
2017-09-12 16:59
라인
Brokerage analyzes profit-sharing structure of Celltrion group
Local stock analysts’ eyes are now on the profit-sharing structure of the C...
by Nam Doo-hyun
|
2017-09-12 16:55
라인
Researchers develop prediction model of breast cancer patients' survival rate
A research team at the Catholic University of Korea Seoul St. Mary's Ho...
by Constance Williams
|
2017-09-12 15:59
라인
EU approves Abbvie’s Humira as first biologic to treat CHMP
Abbvie Korea, the Korean offshoot of the global biopharmaceutical company, ...
by Marian Chu
|
2017-09-12 15:45
라인
Court takes side with druggists despite leakage of personal info
About 2,000 doctors and patients filed a damage suit of 5.4 billion won ($4...
by Lee Hye-seon
|
2017-09-12 15:43
라인
FIP head calls for revitalizing generic substitution
International Pharmaceutical Federation (FIP) has come forward to emphasize...
by Lee Hye-seon
|
2017-09-12 14:34
라인
Inha keeps ahead in international healthcare services
If a foreigner plans to fly to Korea to receive healthcare services, he or ...
by Constance Williams
|
2017-09-12 13:30
라인
Lilly’s diabetes drug ahead of Novo Nordisk’s in Q2 market share
Lilly Korea’s diabetes drug Trulicity grabbed the largest market share in K...
by Marian Chu
|
2017-09-12 13:26
-
이전
281
282
283
284
285
286
287
288
289
290
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top